HM Payson & Co’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-810
| Closed | -$24K | – | 1023 |
|
|
2023
Q4 | $24K | Hold |
810
| – | – | ﹤0.01% | 708 |
|
|
2023
Q3 | $12.9K | Sell |
810
-3,359
| -81% | -$55.9K | ﹤0.01% | 790 |
|
|
2023
Q2 | $78.7K | Buy |
4,169
+3,359
| +415% | +$39.7K | ﹤0.01% | 517 |
|
|
2023
Q1 | $3.11K | Hold |
810
| – | – | ﹤0.01% | 896 |
|
|
2022
Q4 | $4.02K | Hold |
810
| – | – | ﹤0.01% | 819 |
|
|
2022
Q3 | $4K | Hold |
810
| – | – | ﹤0.01% | 874 |
|
|
2022
Q2 | $4K | Hold |
810
| – | – | ﹤0.01% | 920 |
|
|
2022
Q1 | $4K | Hold |
810
| – | – | ﹤0.01% | 939 |
|
|
2021
Q4 | $6K | Hold |
810
| – | – | ﹤0.01% | 936 |
|
|
2021
Q3 | $5K | Hold |
810
| – | – | ﹤0.01% | 913 |
|
|
2021
Q2 | $5K | Hold |
810
| – | – | ﹤0.01% | 902 |
|
|
2021
Q1 | $7K | Hold |
810
| – | – | ﹤0.01% | 913 |
|
|
2020
Q4 | $5K | Hold |
810
| – | – | ﹤0.01% | 938 |
|
|
2020
Q3 | $3K | Hold |
810
| – | – | ﹤0.01% | 935 |
|
|
2020
Q2 | $4K | Hold |
810
| – | – | ﹤0.01% | 812 |
|
|
2020
Q1 | $3K | Hold |
810
| – | – | ﹤0.01% | 852 |
|
|
2019
Q4 | $4K | Hold |
810
| – | – | ﹤0.01% | 878 |
|
|
2019
Q3 | $2K | Hold |
810
| – | – | ﹤0.01% | 915 |
|
|
2019
Q2 | $2K | Buy |
+810
| New | +$1.92K | ﹤0.01% | 925 |
|
|
2019
Q1 | – | Sell |
-810
| Closed | -$4K | – | 282 |
|
|
2018
Q4 | $4K | Buy |
+810
| New | +$4.92K | 0.01% | 109 |
|
Other funds holding IMGN
HM Payson & Co's IMGN Position: Q1 2024 in Review
HM Payson & Co sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 810 shares — an estimated $24K sold.
HM Payson & Co first reported a position in IMGN in Q4 2018 and held it in 20 quarters. The position peaked at $78.7K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- HM Payson & Co reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- HM Payson & Co sold 810 Immunogen Inc shares in Q1 2024, an estimated $24K.
- HM Payson & Co first reported a position in Immunogen Inc in Q4 2018 and held it in 20 quarters.
- HM Payson & Co's Immunogen Inc position peaked at $78.7K in Q2 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on HM Payson & Co's 13F filing for Q1 2024, filed 20 Jun 2024.